GSK's North America pharmaceutical VP departs
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline's president of North American pharmaceutical operations, Chris Viehbacher, has abruptly resigned from the board with immediate effect. Mr Viehbacher, who lost out to Andrew Witty in the GSK leadership race less than a year ago, will step down to pursue "another unspecified opportunity".